Gastroenterology

  • Home
  • Gastroenterology
Headache Relief Shampoo Voted #1 Best New Product in 2019

headache relief shampoo bottles

Dr. D’s Medicated Headache Relief Shampoo is now available. This medicated shampoo will help alleviate headaches simply by soaking it on your head. Finding relief from minor to severe headaches shouldn’t always involve reaching for a bottle of pills. Dr. D is here to give you another option. Our proprietary formula will leave your head feeling better.

BUY NOW! http://headachereliefshampoo.com/product/headache-relief-shampoo/

January 1, 2019Comments OffHeadache Drug Trial | Headache Relief | Headache Shampoo | Headache Study | Headache Therapy
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
Conditions:   Gastric Cancer;   Breast Cancer;   Cervical Cancer;   Lung Cancer
Interventions:   Drug: KK-LC-1 TCR-T cells;   Drug: Aldesleukin 720,000 IU/kg IV every eight hours
Sponsors:   Christian Hinrichs;   Cancer Immunology and Metabolism Center of Excellence at Rutgers Cancer Institute of New Jersey;   T Cure Bioscience;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 30, 2022Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Conditions:   Advanced Solid Tumor;   Metastatic Cancer
Interventions:   Drug: AU-007;   Drug: Aldesleukin
Sponsor:   Aulos Bioscience, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 27, 2022Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer
Conditions:   Gastric Adenocarcinoma;   Oligometastasis;   Stage IV Esophageal Adenocarcinoma AJCC v7;   Stage IV Esophageal Cancer AJCC v7;   Stage IV Gastric Cancer AJCC v7
Interventions:   Drug: Capecitabine;   Drug: Chemotherapy;   Procedure: Conventional Surgery;   Drug: Fluorouracil;   Radiation: Radiation Therapy
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 23, 2022Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard
Condition:   Schizophrenia
Interventions:   Drug: SEP-363856;   Drug: Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole)
Sponsor:   Sunovion
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 23, 2022Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Randomized Trial of EUS-guided Gastrojejunostomy and Surgical Gastrojejunostomy in Gastric Outlet Obstruction
Condition:   Gastric Outlet Obstruction
Interventions:   Procedure: EUS-guided gastrojejunostomy;   Procedure: Surgical gastrojejunostomy
Sponsor:   Orlando Health, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 22, 2022Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours
Conditions:   Endometrial Cancer;   Gastric Cancer;   Metastatic Castration-resistant Prostate Cancer;   Ovarian Cancer;   Colorectal Cancer
Interventions:   Drug: Datopotamab deruxtecan (Dato-DXd);   Drug: AZD5305;   Drug: Durvalumab;   Drug: Capecitabine;   Drug: 5-Fluorouracil;   Drug: Nivolumab;   Drug: Carboplatin;   Drug: Leucovorin LV;   Drug: Bevacizumab
Sponsors:   AstraZeneca;   Daiichi Sankyo, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 20, 2022Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Study of Gastric Motility in EG
Conditions:   Eosinophilic Gastritis;   Gastroparesis;   Gastric Motility Disorder
Intervention:  
Sponsor:   Children’s Hospital Medical Center, Cincinnati
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 15, 2022Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
SH Dr. Chen Gastric Bypass Study
Condition:   Gastric Bypass
Interventions:   Procedure: Gastric bypass with transection of vagal nerves;   Procedure: Gastric bypass without transection of vagal nerves
Sponsors:   Sanford Health;   National Institutes of Health (NIH)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 10, 2022Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer
Conditions:   Stage IV Melanoma;   Advanced Lung Cancer;   Stage IV Non-Small Cell Lung Cancer;   Unresectable Non-Small Cell Lung Carcinoma;   Unresectable Stage III Non-Small Cell Lung Cancer;   Small Cell Lung Cancer Extensive Stage;   Stage IV Merkel Cell Carcinoma;   Stage IV Cutaneous Squamous Cell Carcinoma;   Stage IV Basal Cell Carcinoma;   Stage IV Breast Cancer;   Stage IV Colorectal Cancer;   Stage IV Gastric Cancer;   Stage IV Esophageal Cancer;   Stage IV Hepatocellular Cancer;   Stage IV Renal Cell Carcinoma;   Stage IV Bladder Cancer;   Stage IV Head and Neck Squamous Cell Carcinoma;   Stage IV Cervical Cancer;   Stage IV Endometrial Cancer;   Stage IV Mesothelioma;   Immunotherapy;   Immune Checkpoint Inhibitors
Interventions:   Other: Educational Video and QPL List;   Other: Usual Care
Sponsors:   Massachusetts General Hospital;   Conquer Cancer Foundation
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 2, 2022Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy
Conditions:   Brain Cancer;   Head and Neck Cancer;   Lung Cancer;   Gastric Cancer;   Ovarian Cancer;   Colon Cancer
Intervention:   Device: Halcyon 4.0 system
Sponsors:   Washington University School of Medicine;   Varian Medical Systems
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

August 24, 2022Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine